Welcome to Medications.com
Arpida reports progress in enrollment for Phase III onychomycosis ... - Pharmaceutical Business Review
The TLT therapy consists of a one-time laser pre-treatment, followed by daily application of a topical terbinafine (the active substance of Lamisil) ...
http://www.pharmaceutical-busines... |
Posted: Wed Jan 23 03:44:14 -0500 2008
Lamisil AT RSS FeedFrequently Reported Side Effects of Lamisil AT
© 2002-2007, Skylabs Inc. |
About Us |
Disclaimer/Terms of Use |
Advertise |
Contact Us |
Site Map |
Developed by:
W3matter.com |
Sleep Apnea
